659 related articles for article (PubMed ID: 31535225)
41. Salvage esophagectomy after definitive chemoradiotherapy for synchronous double cancers of the esophagus and head-and-neck.
Yoshida R; Morita M; Ando K; Masuda T; Saeki H; Oki E; Sadanaga N; Nakashima T; Kakeji Y; Maehara Y
Dis Esophagus; 2010 Jan; 23(1):59-63. PubMed ID: 19392844
[TBL] [Abstract][Full Text] [Related]
42. Neoadjuvant concurrent chemoradiotherapy followed by definitive high-dose radiotherapy or surgery for operable thoracic esophageal carcinoma.
Murakami M; Kuroda Y; Okamoto Y; Kono K; Yoden E; Kusumi F; Hajiro K; Matsusue S; Takeda H
Int J Radiat Oncol Biol Phys; 1998 Mar; 40(5):1049-59. PubMed ID: 9539559
[TBL] [Abstract][Full Text] [Related]
43. Role of surgical resection in complete responders on FDG-PET after chemoradiotherapy for locally advanced esophageal squamous cell carcinoma.
Jeong Y; Kim JH; Kim SB; Yoon DH; Park SI; Kim YH; Kim HR; Jung HY; Lee GH; Ryu JS
J Surg Oncol; 2014 Apr; 109(5):472-7. PubMed ID: 24301552
[TBL] [Abstract][Full Text] [Related]
44. Treatments for esophageal cancer: a review.
Kato H; Nakajima M
Gen Thorac Cardiovasc Surg; 2013 Jun; 61(6):330-5. PubMed ID: 23568356
[TBL] [Abstract][Full Text] [Related]
45. [Surgery after upfront radiochemotherapy for locally advanced esophageal cancer: To do or not to do?].
Créhange G; Mabrut JY; Rouffiac M
Cancer Radiother; 2018 Oct; 22(6-7):540-545. PubMed ID: 30174168
[TBL] [Abstract][Full Text] [Related]
46. Surveillance Following Treatment of Esophageal Cancer.
Bakhos CT; Acevedo E; Petrov RV; Abbas AE
Surg Clin North Am; 2021 Jun; 101(3):499-509. PubMed ID: 34048769
[TBL] [Abstract][Full Text] [Related]
47. [Is esophagectomy necessary for esophageal cancer patients with complete response after neoadjuvant chemoradiotherapy].
Fu J; Tan Z
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Sep; 21(9):983-986. PubMed ID: 30269316
[TBL] [Abstract][Full Text] [Related]
48. Prognostic value of endoscopic biopsy findings after induction chemoradiotherapy with and without surgery for esophageal cancer.
Miyata H; Yamasaki M; Takiguchi S; Nakajima K; Fujiwara Y; Konishi K; Morii E; Mori M; Doki Y
Ann Surg; 2011 Feb; 253(2):279-84. PubMed ID: 21169807
[TBL] [Abstract][Full Text] [Related]
49. Neoadjuvant chemoradiation radiation dose levels for surgically resectable esophageal cancer: predictors of use and outcomes.
Buckstein M; Rhome R; Ru M; Moshier E
Dis Esophagus; 2018 May; 31(5):. PubMed ID: 29309563
[TBL] [Abstract][Full Text] [Related]
50. Neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for cancer of the esophagus or gastroesophageal junction: long-term results of a randomized clinical trial.
von Döbeln GA; Klevebro F; Jacobsen AB; Johannessen HO; Nielsen NH; Johnsen G; Hatlevoll I; Glenjen NI; Friesland S; Lundell L; Yu J; Nilsson M
Dis Esophagus; 2019 Feb; 32(2):. PubMed ID: 30137281
[TBL] [Abstract][Full Text] [Related]
51. Results of Neoadjuvant Chemoradiotherapy With Docetaxel and 5-Fluorouracil Followed by Esophagectomy to Treat Locally Advanced Esophageal Cancer.
Hamai Y; Hihara J; Emi M; Murakami Y; Kenjo M; Nagata Y; Okada M
Ann Thorac Surg; 2015 Jun; 99(6):1887-93. PubMed ID: 25912745
[TBL] [Abstract][Full Text] [Related]
52. Comparison Between Esophagectomy and Definitive Chemoradiotherapy in Patients With Esophageal Cancer.
Wang BY; Hung WH; Wu SC; Chen HC; Huang CL; Lin CH; Chen HS
Ann Thorac Surg; 2019 Apr; 107(4):1060-1067. PubMed ID: 30571951
[TBL] [Abstract][Full Text] [Related]
53. Should Multidisciplinary Treatment Differ for Esophageal Adenocarcinoma Versus Esophageal Squamous Cell Cancer?
Cools-Lartigue J; Ferri L
Ann Surg Oncol; 2019 Apr; 26(4):1014-1027. PubMed ID: 30675706
[TBL] [Abstract][Full Text] [Related]
54. Long-term outcomes following neoadjuvant chemoradiotherapy in patients with clinical T2N0 esophageal squamous cell carcinoma.
Chen WH; Chao YK; Chang HK; Tseng CK; Wu YC; Liu YH; Hsieh MJ; Liu HP
Dis Esophagus; 2012 Apr; 25(3):250-5. PubMed ID: 21951719
[TBL] [Abstract][Full Text] [Related]
55. Factors influencing the long-term survival in patients with esophageal cancer who underwent esophagectomy after chemoradiotherapy.
Takeuchi H; Saikawa Y; Oyama T; Ozawa S; Suda K; Wada N; Takahashi T; Nakamura R; Shigematsu N; Ando N; Kitajima M; Kitagawa Y
World J Surg; 2010 Feb; 34(2):277-84. PubMed ID: 20033687
[TBL] [Abstract][Full Text] [Related]
56. [Definitive chemoradiotherapy and salvage esophagectomy for squamous cell carcinoma of the esophagus].
Miyazaki S; Satomi S
Nihon Geka Gakkai Zasshi; 2004 Sep; 105(9):485-8. PubMed ID: 15500090
[TBL] [Abstract][Full Text] [Related]
57. Optimal preoperative neoadjuvant therapy for resectable locally advanced esophageal squamous cell carcinoma.
Leng XF; Daiko H; Han YT; Mao YS
Ann N Y Acad Sci; 2020 Dec; 1482(1):213-224. PubMed ID: 33067818
[TBL] [Abstract][Full Text] [Related]
58. Prospective, open, multicentre Phase I/II trial to assess safety and efficacy of neoadjuvant radiochemotherapy with docetaxel and cisplatin for esophageal carcinoma.
Ma HB; Di ZL; Wen J; Ke Y; Sun X; Ren J
Jpn J Clin Oncol; 2015 Feb; 45(2):169-75. PubMed ID: 25416813
[TBL] [Abstract][Full Text] [Related]
59. Phase II feasibility study of preoperative concurrent chemoradiotherapy with cisplatin plus 5-fluorouracil and elective lymph node irradiation for clinical stage II/III esophageal squamous cell carcinoma.
Hashimoto J; Kato K; Ito Y; Kojima T; Akimoto T; Daiko H; Hamamoto Y; Matsushita H; Katano S; Hara H; Tanaka Y; Saito Y; Nagashima K; Igaki H
Int J Clin Oncol; 2019 Jan; 24(1):60-67. PubMed ID: 30109544
[TBL] [Abstract][Full Text] [Related]
60. Adjuvant therapy for pT1a-m3/pT1b esophageal squamous cell carcinoma after endoscopic resection: Esophagectomy or chemoradiotherapy? A critical review.
Tsou YK; Lee CH; Le PH; Chen BH
Crit Rev Oncol Hematol; 2020 Mar; 147():102883. PubMed ID: 32014674
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
